Cancer clinical trials in the region Bretagne
238 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
1 recruiting site
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
1 recruiting site
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
1 recruiting site
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT04613596
#2023-508922-83-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
16 recruiting sites
Mirati Thérapeutique Inc.
Phase 3
Head and neck cancer
#NCT06496178
#2023-510322-32-00
Oral cavity
Oropharynx
Hypopharynx
Larynx
Squamous cell carcinoma
Locally Advanced
Metastatic
1
Immunotherapy
Chemotherapy
16 recruiting sites
Merus
Phase 3
Kidney cancer
#NCT07011719
#2024-515023-11-00
Clear cell carcinoma
Locally Advanced
Metastatic
1
Immunotherapy
8 recruiting sites
Arcus Biosciences
Phase 3
Lymphoma
#NCT06091865
#2022-502785-25-00
B cell lymphoma
Large B cell lymphoma
None
CD20
None
Systemic Treatment-Naive
16 recruiting sites
Regeneron Pharmaceuticals